News
CALZF
0.560
-5.08%
-0.030
Macquarie Keeps Their Buy Rating on Polynovo (CALZF)
TipRanks · 16h ago
Bell Potter downgrades Polynovo (CALZF) to a Hold
TipRanks · 3d ago
JPMorgan Group Ceases to Be Substantial Holder in PolyNovo
TipRanks · 3d ago
PolyNovo lifts FY26 revenue, boosts cash flow as wound-care portfolio expands
TipRanks · 4d ago
JPMorgan ceases substantial holding in Polynovo
TipRanks · 06/23 23:08
State Street group exits substantial holder position in Polynovo
TipRanks · 06/05 07:38
PolyNovo Strengthens U.S. Burn Trial PMA Bid, Pushes Filing to Late 2026
TipRanks · 05/29 02:17
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Polynovo (OtherCALZF)
TipRanks · 05/07 00:40
PolyNovo tightens share trading rules as global wound-care business expands
TipRanks · 04/30 04:07
PolyNovo names CSL veteran Marthe D’Ombrain as Chief Scientific Officer to drive next-phase growth
TipRanks · 04/21 22:51
PolyNovo Appoints New Director With No Current Securities Interests
TipRanks · 04/01 03:08
PolyNovo strengthens board with appointment of Dr Charmaine Gittleson
TipRanks · 03/24 07:57
PolyNovo Director Robert Douglas Acquires Initial Stake of 151,000 Shares
TipRanks · 03/16 23:48
PolyNovo Director Andrew Lumsden Doubles Indirect Shareholding
TipRanks · 02/27 02:49
Analysts Are Bullish on These Healthcare Stocks: Xencor (XNCR), Polynovo (CALZF)
TipRanks · 02/25 22:50
PolyNovo Posts H1 FY26 Investor Call Recording as NovoSorb Platform Supports Global Growth
TipRanks · 02/25 00:04
Polynovo Earnings Call Highlights Strong Growth Momentum
TipRanks · 02/23 00:21
Polynovo (CALZF) Receives a Buy from Bell Potter
TipRanks · 02/23 00:05
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 02/22 23:40
Macquarie Remains a Buy on Polynovo (CALZF)
TipRanks · 02/22 23:36
More
Webull provides a variety of real-time CALZF stock news. You can receive the latest news about Polynovo through multiple platforms. This information may help you make smarter investment decisions.
About CALZF
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.